Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Topical Tranexamic Acid on Donor Wounds in Burn Patients: A Randomized Placebo-controlled Trial.

Plastic and reconstructive surgery. Global open·2024
Same author

Findings of the neuromuscular blocking agent rocuronium in blood from deceased subjects several months after exposure: A report of two cases.

Forensic science international·2023
Same author

Topical tranexamic acid for prophylaxis of bleeding.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2023
Same author

Safety and Efficacy of Local Tranexamic Acid for the Prevention of Surgical Bleeding in Soft-Tissue Surgery: A Review of the Literature and Recommendations for Plastic Surgery.

Plastic and reconstructive surgery·2022
Same author

Desflurane consumption with automated vapour control systems in two different anaesthesia machines. A randomized controlled study.

Acta anaesthesiologica Scandinavica·2021
Same author

Relative impact of red blood cell transfusion and anaemia on 5-year mortality in cardiac surgery.

Interactive cardiovascular and thoracic surgery·2020

Related Experiment Video

Updated: Jul 6, 2026

Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver
12:27

Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver

Published on: June 16, 2023

[Drugs to reduce transfusion needs during surgery].

Hilde Pleym1

  • 1Avdeling for immunologi og transfusjonsmedisin, St. Olavs Hospital, 7006 Trondheim. hilde.pleym@stolav.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|April 5, 2008
PubMed
Summary

Drug therapies can reduce the need for blood transfusions during and after surgery. Tranexamic acid is effective in certain orthopedic and cardiac procedures, while desmopressin shows no benefit in patients with normal hemostasis.

Related Experiment Videos

Last Updated: Jul 6, 2026

Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver
12:27

Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver

Published on: June 16, 2023

Area of Science:

  • Anesthesiology
  • Hematology
  • Surgical Medicine

Background:

  • Blood components are a scarce and costly resource, and transfusions carry significant risks.
  • Pharmacological interventions can mitigate the reliance on blood transfusions in surgical settings.
  • Minimizing transfusion needs is crucial for patient safety and resource management.

Purpose of the Study:

  • To evaluate the efficacy of specific drugs in reducing perioperative blood transfusion requirements.
  • To identify patient populations and surgical contexts where drug interventions are most beneficial.
  • To compare the effectiveness of tranexamic acid, desmopressin, and recombinant factor VIIa.

Main Methods:

  • Review of existing literature on drug interventions for reducing surgical transfusions.
  • Analysis of studies focusing on tranexamic acid in hip/knee arthroplasty and cardiac surgery.
  • Assessment of desmopressin's utility in patients with normal preoperative hemostasis.
  • Evaluation of recombinant factor VIIa's role in managing massive hemorrhage and uncontrolled bleeding.

Main Results:

  • Tranexamic acid demonstrated a reduction in transfusion needs in total hip/knee arthroplasty and cardiac surgery.
  • Desmopressin did not show a significant benefit in reducing transfusions for patients with normal preoperative hemostasis.
  • Recombinant factor VIIa is considered for massive hemorrhage in trauma, postpartum, and cardiac surgery, and general surgical bleeding.

Conclusions:

  • Tranexamic acid is an effective drug for reducing transfusions in specific orthopedic and cardiac surgeries.
  • Desmopressin is not recommended for reducing transfusions in patients without preoperative hemostatic abnormalities.
  • Recombinant factor VIIa serves as a potential treatment for severe bleeding scenarios across various surgical and trauma contexts.